Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Paradigm Biocapital Advisors LP
Form 13F · Q2 2026

Paradigm Biocapital Advisors LP

CIK 1855655Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$5.3B
Reported book value
28
Positions
12
Quarters on record
Top 50
Positions

Paradigm Biocapital Advisors LP — holdings

Top 28 positions of 28, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc6.4M−4.4%$1.2B22.3%
2NUVALENT INC Nuvalent Inc5.9M+11.3%$732M13.7%
3EWTX Edgewise Therapeutics Inc10.2M+38.7%$415M7.8%
4GMAB Genmab A/S13.1M+64.8%$361M6.8%
5SYRE Spyre Therapeutics Inc3.8M+96.2%$341M6.4%
6APOGEE THERAPEUTICS INC Apogee Therapeutics Inc1.6M+16.9%$209M3.9%
7ORKA Oruka Therapeutics Inc2.1M−7.6%$204M3.8%
8TNGX Tango Therapeutics Inc6.4M+58.6%$199M3.7%
9BLTE Belite Bio Inc1.2M+10.6%$190M3.6%
10ERAS Erasca Inc9.6M−8.1%$175M3.3%
11TARS Tarsus Pharmaceuticals Inc2.8M+8.3%$175M3.3%
12ALNY Alnylam Pharmaceuticals Inc480,000—$144M2.7%
13INSM Insmed Inc1.3M+5.7%$141M2.6%
14MBX Mbx Biosciences Inc2.5M—$138M2.6%
15PCVX Vaxcyte Inc2.1M−55.6%$124M2.3%
16VRDN Viridian Therapeutics Inc6.7M+113.5%$124M2.3%
17OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc8.7M+8.1%$108M2.0%
18JBIO Jade Biosciences Inc2.9M—$63M1.2%
19TYRA Tyra Biosciences Inc1.8M−11.0%$58M1.1%
20ASMB Assembly Biosciences Inc1.6M+133.6%$43M0.8%
21EYPT Eyepoint Inc2.9M−8.0%$41M0.8%
22QUIT Achieve Life Science Inc5.0M—$32M0.6%
23VOR Vor Biopharma Inc1.8M+0.0%$32M0.6%
24MPLT Maplight Therapeutics Inc685,852—$25M0.5%
25KARD Kardigan Inc900,000—$21M0.4%
26LXEO Lexeo Therapeutics Inc4.2M−32.5%$19M0.4%
27EDIT Editas Medicine Inc5.6M—$18M0.3%
28IVA Inventiva Sa4.0M+0.0%$15M0.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.